1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Maprotiline: new trials by email Literature Review of Maprotiline trials Research Report on Maprotiline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma Temozolomide, Tamoxifen, Maprotiline - Glioblastoma, Brain Tumor | Phase 1 | Withdrawn | University of Rochester | 2022-06-01 | 2022-08-22 |
Brain Neoplasms (1) · Glioblastoma (1)